• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征患者感染 COVID-19 后病情更严重。

Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.

机构信息

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Genet Med. 2021 Mar;23(3):576-580. doi: 10.1038/s41436-020-01004-w. Epub 2020 Oct 16.

DOI:10.1038/s41436-020-01004-w
PMID:33060835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7936948/
Abstract

PURPOSE

Rare genetic conditions like Down syndrome (DS) are historically understudied. Infection is a leading cause of mortality in DS, along with cardiac anomalies. Currently, it is unknown how the COVID-19 pandemic affects individuals with DS. Herein, we report an analysis of individuals with DS who were hospitalized with COVID-19 in New York, New York, USA.

METHODS

In this retrospective, dual-center study of 7246 patients hospitalized with COVID-19, we analyzed all patients with DS admitted in the Mount Sinai Health System and Columbia University Irving Medical Center. We assessed hospitalization rates, clinical characteristics, and outcomes.

RESULTS

We identified 12 patients with DS. Hospitalized individuals with DS are on average ten years younger than patients without DS. Patients with DS have more severe disease than controls, particularly an increased incidence of sepsis and mechanical ventilation.

CONCLUSION

We demonstrate that individuals with DS who are hospitalized with COVID-19 are younger than their non-DS counterparts, and that they have more severe disease than age-matched controls. We conclude that particular care should be considered for both the prevention and treatment of COVID-19 in these patients.

摘要

目的

唐氏综合征(DS)等罕见遗传疾病在历史上研究较少。感染是 DS 患者死亡的主要原因之一,还有心脏异常。目前,尚不清楚 COVID-19 大流行如何影响 DS 患者。在此,我们报告了美国纽约市西奈山卫生系统和哥伦比亚大学欧文医学中心因 COVID-19 住院的 DS 患者的分析。

方法

在这项针对 7246 例 COVID-19 住院患者的回顾性、双中心研究中,我们分析了西奈山卫生系统和哥伦比亚大学欧文医学中心收治的所有 DS 患者。我们评估了住院率、临床特征和结局。

结果

我们确定了 12 例 DS 患者。与非 DS 患者相比,住院的 DS 患者平均年轻十岁。DS 患者的疾病比对照组更严重,尤其是败血症和机械通气的发生率更高。

结论

我们表明,因 COVID-19 住院的 DS 患者比非 DS 患者年轻,且与年龄匹配的对照组相比,疾病更严重。我们的结论是,应特别考虑这些患者 COVID-19 的预防和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d66/8629340/98f6101c2869/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d66/8629340/98f6101c2869/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d66/8629340/98f6101c2869/gr1_lrg.jpg

相似文献

1
Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.唐氏综合征患者感染 COVID-19 后病情更严重。
Genet Med. 2021 Mar;23(3):576-580. doi: 10.1038/s41436-020-01004-w. Epub 2020 Oct 16.
2
Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.意大利死于 COVID-19 的唐氏综合征个体的临床特征:一项病例系列研究。
Am J Med Genet A. 2020 Dec;182(12):2964-2970. doi: 10.1002/ajmg.a.61867. Epub 2020 Sep 12.
3
Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil.未接种疫苗的唐氏综合征患者的 COVID-19 临床特征和合并症:巴西的首年报告。
Hum Genet. 2022 Dec;141(12):1887-1904. doi: 10.1007/s00439-022-02468-3. Epub 2022 Jun 28.
4
COVID-19 in patients with Down syndrome.唐氏综合征患者的 COVID-19 感染。
Neurol Sci. 2021 May;42(5):1649-1652. doi: 10.1007/s10072-021-05091-8. Epub 2021 Feb 1.
5
Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.在纽约一家医院中对 4404 人进行的 COVID-19 调查队列研究,以及 ICU 护理和通气的预测因素。
Ann Emerg Med. 2020 Oct;76(4):394-404. doi: 10.1016/j.annemergmed.2020.05.011. Epub 2020 May 11.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA.美国 COVID-19 住院患者心血管合并症及结局的地域差异。
Cardiology. 2021;146(4):481-488. doi: 10.1159/000515064. Epub 2021 Apr 26.
8
Specific Susceptibility to COVID-19 in Adults with Down Syndrome.唐氏综合征成年人对新冠病毒的特殊易感性。
Neuromolecular Med. 2021 Dec;23(4):561-571. doi: 10.1007/s12017-021-08651-5. Epub 2021 Mar 4.
9
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19.严重 COVID-19 适应性风险预测器(SCARP)的开发,是一种用于预测 COVID-19 住院患者发生严重疾病或死亡的计算器。
Ann Intern Med. 2021 Jun;174(6):777-785. doi: 10.7326/M20-6754. Epub 2021 Mar 2.
10
An international survey on the impact of COVID-19 in individuals with Down syndrome.一项关于新冠病毒病对唐氏综合征患者影响的国际调查。
medRxiv. 2020 Nov 5:2020.11.03.20225359. doi: 10.1101/2020.11.03.20225359.

引用本文的文献

1
DYRK1A in blood and immune function: implications in leukemia, inflammatory disorders, infection and Down syndrome.血液中的DYRK1A与免疫功能:对白血病、炎症性疾病、感染及唐氏综合征的影响
Front Cell Dev Biol. 2025 May 30;13:1587089. doi: 10.3389/fcell.2025.1587089. eCollection 2025.
2
Using Video Modeling to Increase Face-Covering Behavior for Individuals with Down Syndrome in the School Setting.在学校环境中使用视频示范来增加唐氏综合征患者的面部遮盖行为。
Trends Psychol. 2023 Mar 14:1-15. doi: 10.1007/s43076-023-00265-z.
3
Global, regional, and national impact of Down syndrome on child and adolescent mortality from 1980 to 2021, with projections to 2050: a cross-sectional study.
1980年至2021年唐氏综合征对儿童和青少年死亡率的全球、区域和国家影响及2050年预测:一项横断面研究
Front Public Health. 2025 Apr 24;13:1554589. doi: 10.3389/fpubh.2025.1554589. eCollection 2025.
4
Down syndrome and outcomes in critically ill pediatric patients.唐氏综合征与危重症儿科患者的预后
Front Pediatr. 2025 Jan 24;12:1483944. doi: 10.3389/fped.2024.1483944. eCollection 2024.
5
Causes of Hospitalization in Children with Down Syndrome.唐氏综合征患儿住院的原因。
Medicina (Kaunas). 2024 Sep 10;60(9):1480. doi: 10.3390/medicina60091480.
6
Comparing research attitudes in Down syndrome and non-Down syndrome research decision-makers.比较唐氏综合征和非唐氏综合征研究决策者的研究态度。
Alzheimers Dement (N Y). 2024 Jul 31;10(3):e12478. doi: 10.1002/trc2.12478. eCollection 2024 Jul-Sep.
7
Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome.对1299名唐氏综合征患者进行的自然史研究中免疫系统的失调
J Clin Immunol. 2024 May 22;44(6):130. doi: 10.1007/s10875-024-01725-6.
8
COVID-19 in patients with Down syndrome: A systematic review.唐氏综合征患者的 COVID-19:系统评价。
Immun Inflamm Dis. 2024 Mar;12(3):e1219. doi: 10.1002/iid3.1219.
9
Tailoring remote special education for children with down syndrome during COVID-19 pandemic in the Philippines.菲律宾新冠疫情期间为唐氏综合征儿童量身定制远程特殊教育
Int J Dev Disabil. 2022 Apr 1;70(1):40-48. doi: 10.1080/20473869.2022.2056404. eCollection 2024.
10
The National Institutes of Health INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan.美国国立卫生研究院全生命周期共病状况调查以了解唐氏综合征(INCLUDE)项目:加速针对唐氏综合征患者全生命周期的研究发现。
Am J Med Genet C Semin Med Genet. 2024 Mar;196(1):e32081. doi: 10.1002/ajmg.c.32081. Epub 2024 Jan 10.